Yayın:
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorAhmet Bılıcı
dc.contributor.authorNuri Karadurmuş
dc.contributor.authorLeyla Özer
dc.contributor.authorDeniz Tural
dc.contributor.authorKaplan Ma
dc.contributor.authorTülay Akman
dc.contributor.authorİbrahim Vedat Bayoğlu
dc.contributor.authorMükremın Uysal
dc.contributor.authorYaşar Yıldız
dc.contributor.authorÖzgür Tanrıverdi
dc.contributor.authorOzan Yazıcı
dc.contributor.authorZeki Sürmeli
dc.contributor.authorN. S. Turhal
dc.contributor.authorSevil Bavbek
dc.contributor.authorFatih Selçukbırıcık
dc.contributor.authorDoğan Koca
dc.contributor.authorMert Başaran
dc.contributor.orcid0000-0002-2884-7970
dc.contributor.orcid0000-0002-0443-6966
dc.contributor.orcid0000-0003-3291-8062
dc.contributor.orcid0000-0002-1430-2662
dc.contributor.orcid0000-0003-2144-6469
dc.contributor.orcid0000-0003-0882-0524
dc.contributor.orcid0000-0002-0481-1084
dc.contributor.orcid0000-0002-8524-0665
dc.contributor.orcid0000-0002-2912-3835
dc.contributor.orcid0000-0002-0598-7284
dc.contributor.orcid0000-0003-0038-3569
dc.contributor.orcid0000-0002-5087-6268
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0002-1273-1674
dc.contributor.orcid0000-0002-6513-0768
dc.contributor.orcid0000-0001-5437-134X
dc.date.accessioned2025-11-13T10:21:57Z
dc.date.issued2017-07-21
dc.identifier.doihttps://doi.org/10.5301/tj.5000635
dc.identifier.endpage450
dc.identifier.issn0300-8916
dc.identifier.issue6
dc.identifier.openalexW2734504312
dc.identifier.startpage444
dc.identifier.urihttps://hdl.handle.net/11421/3927
dc.identifier.urihttps://doi.org/10.5301/tj.5000635
dc.identifier.volume104
dc.language.isoen
dc.relation.ispartofTumori Journal
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectRenal cell carcinoma
dc.subjectPazopanib
dc.subjectInternal medicine
dc.subjectBrain metastasis
dc.subjectOncology
dc.subjectMetastasis
dc.subjectNephrectomy
dc.subjectSystemic therapy
dc.subjectTargeted therapy
dc.subjectMultivariate analysis
dc.subjectCancer
dc.subjectGastroenterology
dc.subjectSunitinib
dc.subjectKidney
dc.subjectBreast cancer
dc.titlePrognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications